Exact Mass: 470.2363
Exact Mass Matches: 470.2363
Found 258 metabolites which its exact mass value is equals to given mass value 470.2363
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Lucidenic acid D1
Lucidenic acid D1 is found in mushrooms. Lucidenic acid D1 is a constituent of Ganoderma lucidum (reishi).
(R)-1-O-[b-D-Glucopyranosyl-(1->6)-b-D-glucopyranoside]-1,3-octanediol
(R)-1-O-[b-D-Glucopyranosyl-(1->6)-b-D-glucopyranoside]-1,3-octanediol is found in fruits. (R)-1-O-[b-D-Glucopyranosyl-(1->6)-b-D-glucopyranoside]-1,3-octanediol is a constituent of calabash tree (Crescentia cujete) fruits. Constituent of calabash tree (Crescentia cujete) fruits. (R)-1-O-[b-D-Glucopyranosyl-(1->6)-b-D-glucopyranoside]-1,3-octanediol is found in fruits.
(2S)-2-Hexylsulfanyl-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]decanamide
N-Methoxysuccinyl-Ala-Ala-Pro-Val
Neokurarinol
Neokurarinol is a natural product found in Sophora flavescens with data available.
3,7,11,12,15-Pentaoxo-25,26,27-trinorlanost-8-en-24-oic acid
{(2S,3R,4R)-2-(3,4-dimethoxyphenyl)-4-[(3,4-dimethoxyphenyl)methyl]tetrahydrofuran-3-yl}methyl (2E)-2-methylbut-2-enoate
17-acetoxy-1-acetyl-10,11-dimethoxy-4-methyl-3,4-seco-cur-19-en-3-one|Acetyl-tabascanin
3-[3-acetyl-5-(3,7-dimethyl-2,6-octadienyl)-2,4,6-trihydroxybenzyl]-6-ethyl-4-hydroxy-5-methyl-2h-pyran-2-one
(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(3-hydroxy-6-methylheptoxy)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
C27H34O7_Methyl [(1S,3S,7R,8R,9R,12S,13S)-13-(3-furyl)-6,6,8,12-tetramethyl-17-methylene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.0~1,12~.0~3,8~]heptadec-7-yl]acetate
(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(3-hydroxy-6-methylheptoxy)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol [IIN-based on: CCMSLIB00000845039]
(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(3-hydroxy-6-methylheptoxy)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol [IIN-based: Match]
Ala Phe His Pro
Ala Phe Pro His
Ala His Phe Pro
Ala His Ile Met
Ala His Leu Met
Ala His Met Ile
Ala His Met Leu
Ala His Pro Phe
Ala Ile His Met
Ala Ile Met His
Ala Leu His Met
Ala Leu Met His
Ala Met His Ile
Ala Met His Leu
Ala Met Ile His
Ala Met Leu His
Ala Pro Phe His
Ala Pro His Phe
Cys His Ile Val
Cys His Leu Val
Cys His Val Ile
Cys His Val Leu
Cys Ile His Val
Cys Ile Val His
Cys Leu His Val
Cys Leu Val His
Cys Val His Ile
Cys Val His Leu
Cys Val Ile His
Cys Val Leu His
Phe Ala His Pro
Phe Ala Pro His
Phe His Ala Pro
Phe His Pro Ala
Phe Pro Ala His
Phe Pro His Ala
His Ala Phe Pro
His Ala Ile Met
His Ala Leu Met
His Ala Met Ile
His Ala Met Leu
His Ala Pro Phe
His Cys Ile Val
His Cys Leu Val
His Cys Val Ile
His Cys Val Leu
His Phe Ala Pro
His Phe Pro Ala
His Ile Ala Met
His Ile Cys Val
His Ile Met Ala
His Ile Val Cys
His Leu Ala Met
His Leu Cys Val
His Leu Met Ala
His Leu Val Cys
His Met Ala Ile
His Met Ala Leu
His Met Ile Ala
His Met Leu Ala
His Pro Ala Phe
His Pro Phe Ala
His Val Cys Ile
His Val Cys Leu
His Val Ile Cys
His Val Leu Cys
Ile Ala His Met
Ile Ala Met His
Ile Cys His Val
Ile Cys Val His
Ile His Ala Met
Ile His Cys Val
Ile His Met Ala
Ile His Val Cys
Ile Met Ala His
Ile Met His Ala
Ile Val Cys His
Ile Val His Cys
Leu Ala His Met
Leu Ala Met His
Leu Cys His Val
Leu Cys Val His
Leu His Ala Met
Leu His Cys Val
Leu His Met Ala
Leu His Val Cys
Leu Met Ala His
Leu Met His Ala
Leu Val Cys His
Leu Val His Cys
Met Ala His Ile
Met Ala His Leu
Met Ala Ile His
Met Ala Leu His
Met His Ala Ile
Met His Ala Leu
Met His Ile Ala
Met His Leu Ala
Met Ile Ala His
Met Ile His Ala
Met Leu Ala His
Met Leu His Ala
Pro Ala Phe His
Pro Ala His Phe
Pro Phe Ala His
Pro Phe His Ala
Pro His Ala Phe
Pro His Phe Ala
Val Cys His Ile
Val Cys His Leu
Val Cys Ile His
Val Cys Leu His
Val His Cys Ile
Val His Cys Leu
Val His Ile Cys
Val His Leu Cys
Val Ile Cys His
Val Ile His Cys
Val Leu Cys His
Val Leu His Cys
methyl ester
(R)-1-O-[b-D-Glucopyranosyl-(1->6)-b-D-glucopyranoside]-1,3-octanediol
Lucidenic acid D1
3-Hydroxy-6-methylheptyl 2-O-?-D-glucopyranosyl-?-D-glucopyranoside
ETHYL 5-(4-(4-(5-CYANO-1H-INDOL-3-YL) BUTYL) PIPERAZIN-1-YL) BENZOFURAN-2- CARBOXYLATE
Alfenta
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
3-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-N,N-dimethyl-4-(pyrrolidin-1-yl)benzene-1-sulfonamide
(2S)-2-Hexylsulfanyl-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]decanamide
[2-(3,4-dimethoxyphenyl)-4-[(3,4-dimethoxyphenyl)methyl]oxolan-3-yl]methyl (E)-2-methylbut-2-enoate
(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-(3-hydroxy-6-methylheptoxy)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
3-(4-fluorophenyl)-1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
(2S,3S,3aR,9bR)-1-acetyl-N-[3-(dimethylamino)propyl]-7-(3-fluorophenyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(1S,5R)-7-[4-[4-[dimethylamino(oxo)methyl]phenyl]phenyl]-N-(2-methoxyphenyl)-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide
(2R,3R,3aS,9bS)-1-acetyl-N-[3-(dimethylamino)propyl]-7-(3-fluorophenyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S)-N-(1-methylpiperidin-2-yl)-2-(6-oxoheptyl)-N-(4-phenyl-1,3-thiazol-2-yl)propanediamide
[1-Acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] dodecanoate
(4R)-4-[(3R,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-7-oxo-3-sulfooxy-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid
[1-[(2-Heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] heptanoate
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] nonanoate
[1-[(2-Hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] octanoate
[1-[(2-Butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] decanoate
[1-[(2-Acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] dodecanoate
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] undecanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] octanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] nonanoate
[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-heptanoyloxypropyl] heptanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] undecanoate
[1-Butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] decanoate
BMS-986187
BMS-986187 is an δ-opioid receptor-selective positive allosteric modulator (PAM) with an EC50 of 0.03 μM and a pKB?of 6.02 (~1?μM). BMS-986187 has no observable PAM activity at the?μ-receptor (EC50=3 μM)[1].
methyl 2-[6-(furan-3-yl)-14-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-16-yl]acetate
methyl 2-[(1s,2s,5s,6s,13r,14r,16s)-6-(furan-3-yl)-14-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-16-yl]acetate
6,9-dihydroxy-7-methyl-4-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one
4-{3a,6,6,9a,11a-pentamethyl-3,4,7,10,11-pentaoxo-1h,2h,5h,5ah,8h,9h-cyclopenta[a]phenanthren-1-yl}pentanoic acid
(4r)-4-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-2,4,7,10,11-pentaoxo-1h,3h,5h,5ah,8h,9h-cyclopenta[a]phenanthren-1-yl]pentanoic acid
(1r,6s,14r,15s,17r,20r,22s)-20-acetyl-10,15-dihydroxy-6,14,18,18,22-pentamethyl-7,13-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-3,9,11-triene-8,19-dione
methyl 2-[(1r,6r)-6-[(1s,3s,6s,7s,10s)-6-(furan-3-yl)-7-methyl-11-methylidene-4-oxo-2,5-dioxatricyclo[5.4.0.0¹,³]undecan-10-yl]-2,2,6-trimethyl-3-oxocyclohexyl]acetate
7a,9,11b-trihydroxy-3-(4-methoxyphenyl)-5a,8,8,11a-tetramethyl-6,7,9,10,11,12-hexahydro-2,5-dioxatetraphen-1-one
[(2s,3r,4r)-4-(3,4-dimethoxybenzyl)-2-(3,4-dimethoxyphenyl)-tetrahydrofuran-3-yl]-methyl(2z)-2-methylbut-2-en-oate
{"Ingredient_id": "HBIN006636","Ingredient_name": "[(2s,3r,4r)-4-(3,4-dimethoxybenzyl)-2-(3,4-dimethoxyphenyl)-tetrahydrofuran-3-yl]-methyl(2z)-2-methylbut-2-en-oate","Alias": "NA","Ingredient_formula": "C27H34O7","Ingredient_Smile": "CC=C(C)C(=O)OCC1C(COC1C2=CC(=C(C=C2)OC)OC)CC3=CC(=C(C=C3)OC)OC","Ingredient_weight": "470.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6210","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10367451","DrugBank_id": "NA"}